The latest financial statement is for the quarter ending 2026-03-31.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|
| Net income | 17,406 | 13,334 | 32,754 |
| Net amortization on securities available for sale | 882 | 1,004 | 2,635 |
| Net gain on sales of securities available for sale | 7,251 | 80 | 534 |
| Provision for credit losses on loans | 1,350 | 1,250 | 4,400 |
| Recovery of off-balance sheet exposures | -150 | 200 | 200 |
| Loan discount accretion | 324 | 1,693 | - |
| Depreciation of premises and equipment | 618 | 587 | 1,881 |
| Loss on disposal of premises and equipment | - | -6 | - |
| Amortization of other intangible assets | 226 | 231 | 690 |
| Amortization of right-of use asset | 140 | 139 | 419 |
| Cash surrender value of bank-owned life insurance | 446 | 455 | 1,206 |
| Amortization of subordinated debt issuance costs | 105 | 194 | 208 |
| Stock-based compensation | 1,270 | 1,081 | 3,118 |
| Deferred income taxes | -239 | 697 | -2,701 |
| Remeasurement of interest rate swap | 139 | -30 | - |
| Accrued interest receivable and other assets | -6,900 | 12,715 | 1,232 |
| Accrued interest payable and other liabilities | -2,869 | 5,235 | -14,527 |
| Net cash provided by operating activities | 15,993 | 6,977 | 20,835 |
| Decrease in bank-owned certificates of deposit | - | 3,658 | 719 |
| Proceeds from sales of securities available for sale | 208,501 | 12,246 | 64,707 |
| Proceeds from unwind of interest rate swaps | 10,403 | - | - |
| Proceeds from maturities, paydowns, payups and calls of securities available for sale | 29,033 | 45,285 | 108,590 |
| Purchases of securities available for sale | 29,574 | 1,990 | 204,111 |
| Net increase in loans | 59,050 | 93,968 | 344,846 |
| Purchase of fhlb stock | 37,974 | 59,690 | - |
| Net decrease (increase) in fhlb stock | - | - | 2,076 |
| Redemption of fhlb stock | 40,698 | 57,865 | - |
| Purchases of premises and equipment | 1,826 | 2,544 | 3,303 |
| Proceeds from sales of foreclosed assets | - | 185 | - |
| Purchase of bank-owned life insurance | - | 0 | 4,630 |
| Redemption of bank-owned life insurance | 1,803 | 0 | 4,361 |
| Net cash used in investing activities | 162,014 | -36,877 | -380,589 |
| Net increase (decrease) in deposits | -14,858 | 27,605 | 205,997 |
| Principal payments on notes payable | - | 0 | 13,750 |
| Proceeds from fhlb advances | 332,000 | 298,000 | 936,500 |
| Principal payments on fhlb advances | 395,500 | 303,000 | 891,500 |
| Issuance of subordinated debt, net of issuance costs | - | -85 | 78,690 |
| Redemption of subordinated debt | - | 20 | 49,980 |
| Preferred stock dividends paid | 1,013 | 1,014 | 3,040 |
| Stock options exercised | 325 | 692 | 1,247 |
| Stock repurchases | - | 0 | 2,191 |
| Shares repurchased for tax withholdings upon vesting of restricted stock-based awards | 218 | 582 | 131 |
| Shares repurchased for tax withholdings upon exercise stock options | 100 | 3 | 30 |
| Net cash provided by financing activities | -79,364 | 21,593 | 261,812 |
| Net change in cash and cash equivalents | 98,643 | -8,307 | -97,942 |
| Cash and cash equivalents beginning | 123,511 | 97,942 | 229,760 |
| Cash and cash equivalents ending | 222,154 | -8,307 | 131,818 |